Focus on the cetirizine use in clinical practice: a reappraisal 30 years later

Abstract Antihistamines are currently one of the most commonly administered categories of drugs. They are used to treat symptoms that are secondary to histamine release, which is typical of certain allergic conditions, including rhinitis, conjunctivitis, asthma, urticaria, and anaphylaxis. Cetirizin...

Full description

Bibliographic Details
Main Authors: Angelo G. Corsico, Salvatore Leonardi, Amelia Licari, Gianluigi Marseglia, Michele Miraglia del Giudice, Diego G. Peroni, Carmelo Salpietro, Giorgio Ciprandi
Format: Article
Language:English
Published: PAGEPress Publications 2019-12-01
Series:Multidisciplinary Respiratory Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40248-019-0203-6
_version_ 1797286809265242112
author Angelo G. Corsico
Salvatore Leonardi
Amelia Licari
Gianluigi Marseglia
Michele Miraglia del Giudice
Diego G. Peroni
Carmelo Salpietro
Giorgio Ciprandi
author_facet Angelo G. Corsico
Salvatore Leonardi
Amelia Licari
Gianluigi Marseglia
Michele Miraglia del Giudice
Diego G. Peroni
Carmelo Salpietro
Giorgio Ciprandi
author_sort Angelo G. Corsico
collection DOAJ
description Abstract Antihistamines are currently one of the most commonly administered categories of drugs. They are used to treat symptoms that are secondary to histamine release, which is typical of certain allergic conditions, including rhinitis, conjunctivitis, asthma, urticaria, and anaphylaxis. Cetirizine belongs to the second-generation family, so, it is very selective for peripheral H1 receptors, is potent and quickly relieves symptoms, exerts additional anti-allergic/anti-inflammatory effects, and is usually well-tolerated. It has been marketed 30 years ago. In these years, a remarkable body of evidence has been built. The current review provides a practical update on the use of cetirizine in clinical practice.
first_indexed 2024-03-07T18:23:39Z
format Article
id doaj.art-47af4b9cdc7f4146b6c3c22df9f26445
institution Directory Open Access Journal
issn 2049-6958
language English
last_indexed 2024-03-07T18:23:39Z
publishDate 2019-12-01
publisher PAGEPress Publications
record_format Article
series Multidisciplinary Respiratory Medicine
spelling doaj.art-47af4b9cdc7f4146b6c3c22df9f264452024-03-02T07:09:36ZengPAGEPress PublicationsMultidisciplinary Respiratory Medicine2049-69582019-12-011411710.1186/s40248-019-0203-6Focus on the cetirizine use in clinical practice: a reappraisal 30 years laterAngelo G. Corsico0Salvatore Leonardi1Amelia Licari2Gianluigi Marseglia3Michele Miraglia del Giudice4Diego G. Peroni5Carmelo Salpietro6Giorgio Ciprandi7Division of Respiratory Diseases, Foundation IRCCS Policlinico San Matteo, University of PaviaDepartment of Clinical and Experimental Medicine, University of CataniaDepartment of Pediatrics, Foundation IRCCS Policlinico San Matteo, University of PaviaDepartment of Pediatrics, Foundation IRCCS Policlinico San Matteo, University of PaviaDepartment of Woman, Child and of General and Specialized Surgery, University of Campania “Luigi Vanvitelli”U.O. Pediatria, Azienda Ospedaliero-Universitaria Pisana, Scuola di Specializzazione in Pediatria, University of PisaDepartment of Pediatrics, Unit of Pediatric Genetics and Immunology, University of MessinaAllergy Clinic, Casa di Cura Villa MontallegroAbstract Antihistamines are currently one of the most commonly administered categories of drugs. They are used to treat symptoms that are secondary to histamine release, which is typical of certain allergic conditions, including rhinitis, conjunctivitis, asthma, urticaria, and anaphylaxis. Cetirizine belongs to the second-generation family, so, it is very selective for peripheral H1 receptors, is potent and quickly relieves symptoms, exerts additional anti-allergic/anti-inflammatory effects, and is usually well-tolerated. It has been marketed 30 years ago. In these years, a remarkable body of evidence has been built. The current review provides a practical update on the use of cetirizine in clinical practice.http://link.springer.com/article/10.1186/s40248-019-0203-6AntihistaminesCetirizineClinical practiceHistamineH1 receptors
spellingShingle Angelo G. Corsico
Salvatore Leonardi
Amelia Licari
Gianluigi Marseglia
Michele Miraglia del Giudice
Diego G. Peroni
Carmelo Salpietro
Giorgio Ciprandi
Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
Multidisciplinary Respiratory Medicine
Antihistamines
Cetirizine
Clinical practice
Histamine
H1 receptors
title Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_full Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_fullStr Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_full_unstemmed Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_short Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_sort focus on the cetirizine use in clinical practice a reappraisal 30 years later
topic Antihistamines
Cetirizine
Clinical practice
Histamine
H1 receptors
url http://link.springer.com/article/10.1186/s40248-019-0203-6
work_keys_str_mv AT angelogcorsico focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT salvatoreleonardi focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT amelialicari focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT gianluigimarseglia focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT michelemiragliadelgiudice focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT diegogperoni focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT carmelosalpietro focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT giorgiociprandi focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater